True or False: A pharmacist is not exposed to greater liability for dispensing a generic medication.

The statement is true because, under Wyoming law, a pharmacist is generally not exposed to greater liability simply by dispensing a generic medication as opposed to a brand-name medication. The law recognizes that generics are equivalent to their brand-name counterparts in dosage form, strength, route of administration, and intended use.

Pharmacists must still adhere to the same standards of care and due diligence when dispensing either type of medication. This means that the pharmacist is expected to ensure that the medication is appropriate for the patient, regardless of whether it is a generic or a brand name. Therefore, as long as the pharmacist follows the necessary protocols and guidelines, dispensing a generic does not inherently increase their liability.

Factors such as whether the generic has been approved by the FDA and is therapeutically equivalent to the brand-name drug are crucial, but these do not alter the fundamental liability issue — that pharmacists bear the same responsibility when dispensing either type of medication. In situations where misbranding or substitution occurs without proper authorization or notification, liability may arise, but that is based on specific circumstances rather than the choice to dispense a generic. Thus, the statement stands true.